SPERO ONCOLOGY

Spero Oncology has joined Veristat, a US-based full service CRO with over 20 years of experience supporting pharmaceutical, biotechnology and medical device firms throughout the clinical trials and regulatory process, primarily in the United States and Canada. Together, we can make a difference for you by offering more services, in more countries, with more therapeutic and scientific expertise, to help you bring your novel therapies to market sooner.